JPRN-jRCT2080223429未知2 期
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Trial to Assess the Safety and Efficacy of 0.3% and 1% OPA-15406 Ointments When Administered for 4 Weeks in Pediatric Patients With Atopic Dermatitis
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 2age old 至 <= 14age old（—）
- 性别
- All
入选标准
- •Diagnosis of atopic dermatitis based on the criteria of Hanifin and Rajka
排除标准
- •- Subjects who have an atopic dermatitis or contact dermatitis flare-up defined as a sudden intensification of atopic dermatitis.
- •- Subjects who have an active viral skin infection.
- •- Subjects with a current or history of malignancy.
研究者
相似试验
进行中（未招募）
1 期
Study of Topical Application of a Gel Containing the Investigational Active Ingredient Patidegib versus the same Gel Without Patidegib (Placebo) for the Prevention of New Facial Skin Tumors (Basal Cell Carcinomas) in People with Gorlin Syndrome.EUCTR2018-001462-42-ITPellePharm, Inc.150
进行中（未招募）
1 期
A 1-year Study of Topical Application of a Gel Containing the Investigational Active Ingredient Patidegib versus the same Gel Without Patidegib (Placebo) for the Prevention of New Facial Skin Tumors (Basal Cell Carcinomas) in People with Gorlin SyndromeBasal Cell Nevus SyndromeMedDRA version: 20.1Level: LLTClassification code 10004151Term: Basal cell nevus syndromeSystem Organ Class: 100000004850EUCTR2018-001462-42-GBPellePharm, Inc.150
进行中（未招募）
1 期
A 1-year Study of Topical Application of a Gel Containing the Investigational Active Ingredient Patidegib versus the same Gel Without Patidegib (Placebo) for the Prevention of New Facial Skin Tumors (Basal Cell Carcinomas) in People with Gorlin SyndromeBasal Cell Nevus SyndromeMedDRA version: 20.1Level: LLTClassification code 10004151Term: Basal cell nevus syndromeSystem Organ Class: 100000004850EUCTR2018-001462-42-NLPellePharm, Inc.150
招募中
1 期
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromeGorlin SyndromeMedDRA version: 20.1Level: LLTClassification code: 10004151Term: Basal cell nevus syndrome Class: 10010331MedDRA version: 20.0Level: LLTClassification code: 10078877Term: Gorlin-Goltz syndrome Class: 10010331CTIS2023-507528-21-00Sol-Gel Technologies Ltd.156
进行中（未招募）
1 期
A 1-year Study of Topical Application of a Gel Containing the Investigational Active Ingredient Patidegib versus the same Gel Without Patidegib (Placebo) for the Prevention of New Facial Skin Tumors (Basal Cell Carcinomas) in People with Gorlin SyndromeBasal Cell Nevus SyndromeMedDRA version: 20.1Level: LLTClassification code 10004151Term: Basal cell nevus syndromeSystem Organ Class: 100000004850EUCTR2018-001462-42-DKPellePharm, Inc.150